{"transactions":[{"id":4638808,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-09T21:12:52.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":false,"shares":39494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The amount reported in column 9 reflects 175,283 restricted stock units outstanding following the January 22, 2026 settlement, plus 133,333 restricted stock units granted on January 28, 2026 and previously reported, less 39,494 restricted stock units settled on September 30, 2026."}],"balance_after":269122,"derivative":{"underlying":"Common Stock","underlying_shares":39494},"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":4638807,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-09T21:12:52.000Z","date":"2026-01-22","kind":"exercise","planned":false,"acquired":false,"shares":48147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."}],"balance_after":175283,"derivative":{"underlying":"Common Stock","underlying_shares":48147},"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":4638806,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-09T21:12:52.000Z","date":"2026-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":14613,"price":0.97,"value":14174.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The 381,644 amount previously reported in column 5 of Table I of the Reporting Person's Form 4/A filed April 30, 2026 combined issued shares of common stock and unvested restricted stock units and did not reflect the 17,814 shares withheld on January 22, 2026. This Form 4 reports issued shares of common stock in Table I and unvested restricted stock units separately in Table II. After giving effect to the January 22, 2026 vesting and withholding and the January 28, 2026 restricted stock unit grant, the correct balances were 55,214 shares of common stock and 308,616 restricted stock units."}],"balance_after":80095,"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":4638805,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-09T21:12:52.000Z","date":"2026-09-30","kind":"exercise","planned":false,"acquired":true,"shares":39494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":94708,"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":4638804,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-09T21:12:52.000Z","date":"2026-01-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":17814,"price":1.18,"value":21020.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date."}],"balance_after":55214,"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":4638803,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-09T21:12:52.000Z","date":"2026-01-22","kind":"exercise","planned":false,"acquired":true,"shares":48147,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":73028,"source":{"system":"sec-edgar","filing":"0001213900-26-108573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1975028/000121390026108573/ownership.xml","form_type":"4"}},{"id":781930,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-12T20:30:08.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 9, 2026; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":22000,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001975028-26-000002","document":"form4-05122026_040505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000197502826000002/form4-05122026_040505.xml","form_type":"4"}},{"id":796990,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-30T19:38:10.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":381644,"source":{"system":"sec-edgar","filing":"0001213900-26-050133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026050133/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-16"}},{"id":937331,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-16T21:13:58.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units, or RSUs, granted on January 7, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":381644,"source":{"system":"sec-edgar","filing":"0001213900-26-005146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026005146/ownership.xml","form_type":"4"}},{"id":1027488,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2025-10-02T20:05:10.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":false,"shares":39494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date."}],"balance_after":223430,"derivative":{"underlying":"Common Stock","underlying_shares":39494},"source":{"system":"sec-edgar","filing":"0001213900-25-095391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025095391/ownership.xml","form_type":"4"}},{"id":1027487,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:10.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":14613,"price":1.58,"value":23088.54,"ownership":{"direct":true},"balance_after":24881,"source":{"system":"sec-edgar","filing":"0001213900-25-095391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025095391/ownership.xml","form_type":"4"}},{"id":1027486,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-02T20:05:10.000Z","date":"2025-09-30","kind":"exercise","planned":false,"acquired":true,"shares":39494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":39494,"source":{"system":"sec-edgar","filing":"0001213900-25-095391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390025095391/ownership.xml","form_type":"4"}},{"id":1151912,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-12T20:15:22.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":63150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":63150,"derivative":{"exercise_price":0.17,"expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":63150},"source":{"system":"sec-edgar","filing":"0001415889-25-012653","document":"form4-05122025_040518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012653/form4-05122025_040518.xml","form_type":"4"}},{"id":1155873,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:17.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":2049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":2049,"derivative":{"exercise_price":0.45,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001415889-25-012292","document":"form4-05072025_080513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012292/form4-05072025_080513.xml","form_type":"4"}},{"id":1155872,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:17.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 2,049 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 2,049 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001415889-25-012292","document":"form4-05072025_080513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012292/form4-05072025_080513.xml","form_type":"4"}},{"id":1295680,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"officer":true,"officer_title":"CDO"}}],"security":"Common Stock","published_at":"2025-01-24T21:18:52.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":144441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":262924,"source":{"system":"sec-edgar","filing":"0001437749-25-001808","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000143774925001808/rdgdoc.xml","form_type":"4"}},{"id":1322541,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:15:23.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":47697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":47697,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":47697},"source":{"system":"sec-edgar","filing":"0001415889-24-030065","document":"form4-12232024_041220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924030065/form4-12232024_041220.xml","form_type":"4"}},{"id":1396866,"issuer":{"id":7594,"kind":"organization","name":"Allarity Therapeutics, Inc.","symbol":"ALLR"},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-01T21:34:12.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":118483,"price":2.11,"value":249999.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 118,483 restricted stock units, or RSUs, in connection with the Reporting Person's appointment as President and Chief Development Officer of the Issuer. The RSUs will vest in equal one-third installments on the first, second, and third anniversary of the Reporting Person's appointment, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":118483,"source":{"system":"sec-edgar","filing":"0001213900-24-084163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390024084163/ownership.xml","form_type":"4"}},{"id":1478409,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:00:17.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to\nthe Reporting Person continuing to provide service through each such date."}],"balance_after":33650,"derivative":{"exercise_price":1.47,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":33650},"source":{"system":"sec-edgar","filing":"0001415889-24-016968","document":"form4-06142024_050612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924016968/form4-06142024_050612.xml","form_type":"4"}},{"id":1708671,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:27:08.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":2049,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,049 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 2,049 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":2049,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001209191-23-058721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058721/doc4.xml","form_type":"4"}},{"id":1708670,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:27:08.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":2049,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,049 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 2,049 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":2049,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":2049},"source":{"system":"sec-edgar","filing":"0001209191-23-058721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058721/doc4.xml","form_type":"4"}},{"id":1708669,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T13:27:08.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":2049,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,049 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 2,049 shares of common stock."}],"balance_after":4549,"source":{"system":"sec-edgar","filing":"0001209191-23-058721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058721/doc4.xml","form_type":"4"}},{"id":1779749,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-15T20:51:57.000Z","date":"2023-09-13","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.95,"value":2375.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-23-049607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123049607/doc4.xml","form_type":"4"}},{"id":1851245,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T23:43:35.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 15, 2023 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":85000,"derivative":{"exercise_price":2.12,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-23-038120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123038120/doc4.xml","form_type":"4"}},{"id":1905504,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47896,"kind":"person","name":"Graff Jeremy R.","position":1,"cik":"0001975028","reported_name":"Graff Jeremy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-03T20:55:10.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares subject to the option shall vest in equal monthly installments commencing on June 1, 2023, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":27000,"derivative":{"exercise_price":1.74,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-027027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123027027/doc4.xml","form_type":"4"}}]}